Trader consensus on Polymarket reflects low implied probabilities for an OpenAI IPO in 2026, driven by recent reports of missed revenue and user growth targets amid fierce competition from Anthropic and Google, alongside massive $600 billion compute commitments straining finances. CFO Sarah Friar has flagged a 2026 listing as aggressive, shifting expectations toward a second-half regulatory filing and potential 2027 debut, following the company's October 2025 for-profit transition to a public benefit corporation. Intensifying scrutiny—including a fresh House Oversight probe into CEO Sam Altman's pre-IPO dealings and calls for SEC vetting—adds delays, with Sam Altman's upcoming testimony in the Musk lawsuit as a key near-term catalyst.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$1,203,049 Vol.

June 30, 2026
2%

December 31, 2026
27%
$1,203,049 Vol.

June 30, 2026
2%

December 31, 2026
27%
The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If OpenAI is acquired by another company that is already public, this market will immediately resolve to "No."
The resolution source for this market is a consensus of credible reporting.
Market Opened: Oct 29, 2025, 8:28 PM ET
Resolver
0x65070BE91...The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If OpenAI is acquired by another company that is already public, this market will immediately resolve to "No."
The resolution source for this market is a consensus of credible reporting.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects low implied probabilities for an OpenAI IPO in 2026, driven by recent reports of missed revenue and user growth targets amid fierce competition from Anthropic and Google, alongside massive $600 billion compute commitments straining finances. CFO Sarah Friar has flagged a 2026 listing as aggressive, shifting expectations toward a second-half regulatory filing and potential 2027 debut, following the company's October 2025 for-profit transition to a public benefit corporation. Intensifying scrutiny—including a fresh House Oversight probe into CEO Sam Altman's pre-IPO dealings and calls for SEC vetting—adds delays, with Sam Altman's upcoming testimony in the Musk lawsuit as a key near-term catalyst.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions